Skip to content

SCHEDULE 13GAccepted May 15, 5:05 PM ET

Maze Therapeutics, Inc. SCHEDULE 13G

ARCH Venture Fund X, L.P.

Accepted (ET)

5:05 PM

May 15, 2025

Filed

May 15, 2025

Documents

2

Size

37.1 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.